Literature DB >> 24085800

SDF-1/CXCR4 axis promotes directional migration of colorectal cancer cells through upregulation of integrin αvβ6.

Ben Wang1, Wenke Wang, Weibo Niu, Enyu Liu, Xiangjuan Liu, Jiayong Wang, Cheng Peng, Song Liu, Ling Xu, Lei Wang, Jun Niu.   

Abstract

Colorectal cancer (CRC) displays a predilection for metastasis to liver. Although stromal cell-derived factor-1 (SDF-1)/CXCR4 plays an important role in the liver metastasis, the molecular mechanism still remains obscure. We previously reported that integrin αvβ6 was implicated in the progression of CRC. However, no data are currently available on the cross talk between CXCR4 and αvβ6. In the present study, we first demonstrated the cross talk between CXCR4 and αvβ6 and their role in liver metastasis of CRC. We analyzed 159 human CRC samples and found that expression of CXCR4 and αvβ6 was significantly associated with liver metastasis, and interestingly expression of αvβ6 significantly correlated with expression of CXCR4. Both CXCR4 and αvβ6 were highly expressed in metastatic CRC cell lines HT-29 and WiDr, whereas both of them were exiguous in non-metastatic cell line Caco-2. Furthermore, inhibition of αvβ6 significantly decreased SDF-1α-induced cell migration in vitro. SDF-1/CXCR4 could upregulate αvβ6 expression through phosphorylation of ERK and activation of Ets-1 transcription factor. In conclusion, we demonstrate that SDF-1/CXCR4 induces directional migration and liver metastasis of CRC cells by upregulating αvβ6 through ERK/Ets-1 pathway. These data support combined inhibition of CXCR4 and αvβ6 to prevent development of liver metastasis of CRC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24085800     DOI: 10.1093/carcin/bgt331

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  30 in total

1.  Oncogenic potential of TSTA3 in breast cancer and its regulation by the tumor suppressors miR-125a-5p and miR-125b.

Authors:  Yanan Sun; Xiaohong Liu; Qingfu Zhang; Xiaoyun Mao; Liang Feng; Peng Su; Hao Chen; Yang Guo; Feng Jin
Journal:  Tumour Biol       Date:  2015-11-03

2.  The SDF-1/CXCR4 axis induces epithelial–mesenchymal transition in hepatocellular carcinoma.

Authors:  Xuqi Li; Pei Li; Yuanhong Chang; Qinhong Xu; Zheng Wu; Qingyong Ma; Zheng Wang
Journal:  Mol Cell Biochem       Date:  2014-07       Impact factor: 3.396

3.  Silencing of CXCR4 and CXCR7 expression by RNA interference suppresses human endometrial carcinoma growth in vivo.

Authors:  Yu Huang; Yuanying Ye; Ping Long; Shuping Zhao; Lei Zhang; Yanni A
Journal:  Am J Transl Res       Date:  2017-04-15       Impact factor: 4.060

4.  Nonsecreted cytoplasmic alpha-fetoprotein: a newly discovered role in intracellular signaling and regulation. An update and commentary.

Authors:  G J Mizejewski
Journal:  Tumour Biol       Date:  2015-07-12

5.  Integrin β6 can be translationally regulated by eukaryotic initiation factor 4E: Contributing to colonic tumor malignancy.

Authors:  Liu Enyu; Niu Zhengchuan; Wang Jiayong; Liang Benjia; Sun Qi; Qin Ruixi; Peng Cheng; Abdul Qadir Khan; Song Wei; Niu Jun
Journal:  Tumour Biol       Date:  2015-05-17

Review 6.  Process of hepatic metastasis from pancreatic cancer: biology with clinical significance.

Authors:  Haojun Shi; Ji Li; Deliang Fu
Journal:  J Cancer Res Clin Oncol       Date:  2015-08-07       Impact factor: 4.553

7.  LPS-induced CXCR4-dependent migratory properties and a mesenchymal-like phenotype of colorectal cancer cells.

Authors:  Wen-Ting Liu; Ying-Ying Jing; Fei Yan; Zhi-Peng Han; Fo-Bao Lai; Jian-Xing Zeng; Guo-Feng Yu; Qing-Min Fan; Rong Li; Qiu-Dong Zhao; Meng-Chao Wu; Li-Xin Wei
Journal:  Cell Adh Migr       Date:  2016-01-08       Impact factor: 3.405

Review 8.  Slit/Robo pathway: a promising therapeutic target for cancer.

Authors:  Rishi K Gara; Sonam Kumari; Aditya Ganju; Murali M Yallapu; Meena Jaggi; Subhash C Chauhan
Journal:  Drug Discov Today       Date:  2014-09-20       Impact factor: 7.851

9.  Integrin β6 acts as an unfavorable prognostic indicator and promotes cellular malignant behaviors via ERK-ETS1 pathway in pancreatic ductal adenocarcinoma (PDAC).

Authors:  Zequn Li; Pengfei Lin; Chao Gao; Cheng Peng; Song Liu; Huijie Gao; Ben Wang; Jiayong Wang; Jun Niu; Weibo Niu
Journal:  Tumour Biol       Date:  2015-11-07

10.  Effect of integrin α5β1 inhibition on SDF-l/CXCR4-mediated choroidal neovascularization.

Authors:  Yang Lyu; Wen-Qin Xu; Li-Juan Sun; Xiao-Yan Pan; Jian Zhang; Yu-Sheng Wang
Journal:  Int J Ophthalmol       Date:  2018-05-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.